In addition, 6/10 (60%) of the BCAR1-G23V vaccination group, 5/10 (50%) of the PLCG1-M425L vaccination group and 3/10 (30%) of the ACAD8-T105I vaccination group exhibited prolonged long-term survival (over 80 days) after tumor inoculation (Figure 5B), whereas all the mice in the control groups died between days 19 and 40. This evidence concerns the gene ACAD8 and neoplasm.